Optimal Sleep Length Identified to Ward Off Insulin Resistance
Medically reviewed by Drugs.com
via HealthDayFRIDAY, March 6, 2026 -- Sleeping for seven hours and 18 minutes every night may help ward off the risk for insulin resistance, according to a study published online March 3 in BMJ Open Diabetes Research & Care.
Zhanhong Fan, from the School of Nursing and Rehabilitation at Nantong University in China, and colleagues used data from 23,475 participants in the National Health and Nutrition Examination Survey (2009 to 2023) to examine the association between weekday sleep duration and estimated glucose disposal rate (eGDR), along with the moderating role of weekend catch-up sleep (WCS).
The researchers identified an inverted U-shaped relationship between weekday sleep duration and eGDR, with an inflection point at 7.32 hours. Below this threshold, increased sleep improved eGDR (β = 0.273), but exceeding the threshold was inversely associated with eGDR (β = −0.222). For those with <7.32 hours of weekday sleep, one to two hours of WCS was associated with increased eGDR (β = 0.296) versus no WCS. However, more than two hours of WCS negatively moderated the relationship between weekday sleep and eGDR (β = −0.568).
"There appears to be a bidirectional relationship between sleep and metabolism," the authors write. "This creates a potential vicious cycle wherein metabolic dysregulation disrupts normal sleep patterns, and the resultant abnormal sleep (including extended duration) further aggravates metabolic health."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-07 08:42
Read more
- Wildfire Smoke Exposure During Pregnancy May Increase Autism Risk in Offspring
- Baby Maintenance: Bath, Nails, and Hair
- Diltiazem Linked to Increased Risk for Bleeding Complications in A-Fib
- Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
- AAAAI: No Increase Seen in Asthma Exacerbations With ICI Use for Melanoma, Renal Cell Carcinoma
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions